FDA – Page 13 – Policy & Medicine

FDA Announces End of Unapproved Drugs Initiative

FDA Proposes Clarifying Intended Use Regulations

FDA Draft Guidance on Postmarking Reporting

FDA Temporary Guidance Outlines Path for Manufacturing to Return to Normal

Trump Administration Finalizes Drug Importation Rule

FDA Holds Public Meeting on Communication with Industry

HHS OIG Releases Report on Effectiveness of REMS

OPDP Issues Third Enforcement Letter of 2020

OPDP Sends First Untitled Letter of 2020

FDA Releases COVID-19 Guidance on Drug Sample Distribution Requirements